Nykode Therapeutics ASA
OSE:NYKD
Intrinsic Value
The intrinsic value of one NYKD stock under the Base Case scenario is 0.287 NOK. Compared to the current market price of 2.406 NOK, Nykode Therapeutics ASA is Overvalued by 88%.
The Intrinsic Value is calculated as the average of DCF and Relative values:
Valuation History
Nykode Therapeutics ASA
Fundamental Analysis

Revenue & Expenses Breakdown
Nykode Therapeutics ASA
Balance Sheet Decomposition
Nykode Therapeutics ASA
Current Assets | 117.1m |
Cash & Short-Term Investments | 115.4m |
Receivables | 1.7m |
Non-Current Assets | 36.4m |
PP&E | 7.7m |
Intangibles | 72k |
Other Non-Current Assets | 28.6m |
Free Cash Flow Analysis
Nykode Therapeutics ASA
USD | |
Free Cash Flow | USD |
Earnings Waterfall
Nykode Therapeutics ASA
Revenue
|
8.7m
USD
|
Operating Expenses
|
-57m
USD
|
Operating Income
|
-48.3m
USD
|
Other Expenses
|
9.5m
USD
|
Net Income
|
-38.8m
USD
|
NYKD Profitability Score
Profitability Due Diligence
Nykode Therapeutics ASA's profitability score is 5/100. The higher the profitability score, the more profitable the company is.
Score
Nykode Therapeutics ASA's profitability score is 5/100. The higher the profitability score, the more profitable the company is.
NYKD Solvency Score
Solvency Due Diligence
Nykode Therapeutics ASA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Score
Nykode Therapeutics ASA's solvency score is 75/100. The higher the solvency score, the more solvent the company is.
Wall St
Price Targets
NYKD Price Targets Summary
Nykode Therapeutics ASA
According to Wall Street analysts, the average 1-year price target for NYKD is 9.18 NOK with a low forecast of 2.525 NOK and a high forecast of 26.25 NOK.
Dividends
Current shareholder yield for NYKD is .
Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?
The intrinsic value of one NYKD stock under the Base Case scenario is 0.287 NOK.
Compared to the current market price of 2.406 NOK, Nykode Therapeutics ASA is Overvalued by 88%.